Rober to exhibit full range of pioneering mattress solutions at MEDICA 2016

NewsGuard 100/100 Score

A UK company, who specialises in the development and manufacture of ‘zero pressure’ technology will be at MEDICA 2016 to showcase their full range of pioneering mattress solutions.

Over the last few years, Rober has invested heavily in R&D to develop a complete range of pressure ulcer mattresses that cater for a variety of needs including patients that are immobile, bariatric or have existing pressure injuries.

Developed in conjunction with clinicians, the mattresses feature clinically proven technology that prevents pressure injuries from developing. They also have therapeutic properties that promote the healing of established ulcers.

The mattresses are fully automatic, and patients nursed upon them require less frequent manual repositioning, thus relieving the pressure on busy nursing staff. They can be used in everyday nursing environments, as well as acute care facilities.

Mike Hutson, Chief Executive of Rober, said:

Designed and manufactured in the UK, Rober’s mattresses, overlays and cushions have been developed to replicate the body’s natural movements by responding to a patient’s weight, spontaneous movement pattern and body position. They provide enhanced comfort and complete pressure elimination at regular intervals.

Pressure ulcers are a rising problem around the world and in the UK alone, they affect over 700,000 people a year and add an additional £4,000 per ulcer onto each person’s care bill. They are also linked to prolonged hospitalisation, pain, social isolation and in worst cases, death.

MEDICA 2016 is taking place from 14 – 17 November 2016 and throughout the show, Rober will be located in in hall 16, stand G20-02.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative diabetes detection method with DiaNet v2, utilizing retinal imaging technology